G. Papini

Evaluation of the effects of cyclododecane on oil paintings

F. Modugno, G. Papini, L. Borgioli, 2018 .

Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia.

E. Cencini, A. Fabbri, F. Lauria, 2014, Leukemia research.

Intravenous (IV) bortezomib infusion after non‐response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?

A. Gozzetti, M. Bocchia, G. Papini, 2017, British journal of haematology.

Therapeutic Advancements in Multiple Myeloma

A. Gozzetti, M. Bocchia, G. Papini, 2014, Front. Oncol..

Extramedullary multifocal plasmacytoma relapse in multiple myeloma.

F. Lauria, A. Gozzetti, E. Marchini, 2012, Leukemia research.

Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET

A. Cerase, A. Gozzetti, M. Bocchia, 2012, Mediterranean journal of hematology and infectious diseases.

Lenalidomide Activity in Multiple Myeloma Relapse E

A. Cerase, A. Gozzetti, M. Bocchia, 2012 .

Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia

P. Musto, A. Gozzetti, M. Bocchia, 2012, British journal of haematology.